Year of publication
Type of media
Source
Type of material
Licence
Language
1–20 of 1,621 hits
Sort by:
Sort by:
-
The Emerging Role of Janus Kinase Inhibitors in the Treatment of Cancer
Free accessBentham Science Publishers | 2022| -
Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors Associated with Hepatocellular Carcinoma
Bentham Science Publishers | 2022| -
Pharmacological Targeting of Ferroptosis in Cancer Treatment
Free accessBentham Science Publishers | 2022| -
Dysregulated Epigenetics of Chordoma: Prognostic Markers and Therapeutic Targets
Bentham Science Publishers | 2022| -
Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as Anticancer Agent
Bentham Science Publishers | 2023| -
Anti-cancer Effects of 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside (AICAR) on Triple-negative Breast Cancer (TNBC) Cells: Mitochondrial Modulation as an Underlying Mechanism
Free accessBentham Science Publishers | 2022| -
Durable Disease-free Survival in a Patient with Metastatic Triple-negative Breast Cancer Treated with Olaparib Monotherapy
Free accessBentham Science Publishers | 2022| -
Systematic Analysis of the Expression Profile and Prognostic Significance of the IGF2BP Family in Lung Adenocarcinoma
Free accessBentham Science Publishers | 2022| -
The Potential of Natural Products in the Treatment of Triple-negative Breast Cancer
Bentham Science Publishers | 2022| -
Promotion of Cervical Cancer Cell Proliferation by miR-130b Expression Level Changes and Inhibition of its Apoptosis by Targeting CDKN1A Gene
Free accessBentham Science Publishers | 2022| -
Genome-Wide CRISPR-Cas9 Screening and Identification of Potential Genes Promoting Prostate Cancer Growth and Metastasis
Bentham Science Publishers | 2023| -
Traditional and Novel Computer-Aided Drug Design (CADD) Approaches in the Anticancer Drug Discovery Process
Bentham Science Publishers | 2023| -
Preparation of Modified Chitosan-based Nanoparticles for Efficient Delivery of Doxorubicin and/or Cisplatin to Breast Cancer Cells
Free accessBentham Science Publishers | 2022| -
Peroxisome Proliferator-activated Receptor Gamma Coactivator-1 Alpha: A Double-edged Sword in Prostate Cancer
Bentham Science Publishers | 2022| -
Localized Nano-mediated Interleukin-12 Gene Therapy: Promising Candidate for Cancer Immunotherapeutics
Bentham Science Publishers | 2022| -
Downregulation of CCKBR Expression Inhibits the Proliferation of Gastric Cancer Cells, Revealing a Potential Target for Immunotoxin Therapy
Free accessBentham Science Publishers | 2022| -
The Current and Evolving Role of Immunotherapy in Metastatic Colorectal Cancer
Bentham Science Publishers | 2022| -
Modulation of ATP8B1 Gene Expression in Colorectal Cancer Cells Suggest its Role as a Tumor Suppressor
Bentham Science Publishers | 2022| -
Targeting Ferroptosis Pathways: A Novel Strategy for Cancer Therapy
Free accessBentham Science Publishers | 2022| -
The Expression of Glutaminases and their Association with Clinicopathological Parameters in the Head and Neck Cancers
Free accessBentham Science Publishers | 2022|
Send my search to (beta)
Send your search query (search terms without filters) to other databases, portals and catalogues to find more interesting hits.
Dimensions:
full data search
or
title and abstract search
Dimensions is a database for abstracts and citations that links information on research funding with the resulting publications, studies and patents.
TIB AV portal
In the TIB AV-Portal, audiovisual media from science and teaching can be foundand own scientific videos can be published.
Specialised Information Service for Mobility and Transport Research (FID move)
Open Research Knowledge Graph (ORKG)
The FID move can be used to search for subject-specific literature, research data and other information from mobility and transport research.
The Open Research Knowledge Graph provides structured descriptions of research content and makes it comparable.
Common Union Catalogue (GVK)
Freely accessible part of the collaborative K10plus catalogue with materials relevant for interlibrary loan and direct delivery services.